Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Earnings call: Arcadia Biosciences reports growth driven by GoodWheat and Zola, explores strategic alternatives

EditorRachael Rajan
Published 10/11/2023, 16:04
Updated 10/11/2023, 16:04
© Reuters.

Arcadia Biosciences (NASDAQ:RKDA), Inc. reported a 20% quarterly revenue increase in Q3 2023, driven by the growth of its GoodWheat pasta and Zola Coconut Water products. The company anticipates further growth from GoodWheat pasta and the introduction of new products into the breakfast category. Arcadia is also actively exploring strategic alternatives, including acquisitions, asset sales, mergers, or other transactions.

Key highlights from the call include:

  • Arcadia's Q3 revenues increased 2% year-over-year, and gross margins improved to 31%.
  • Research and development expenses were $305,000, largely due to the launches of new GoodWheat products.
  • Selling, general, and administrative expenses were 18% below the prior year.
  • The company ended Q3 with cash and short-term investments worth $15.7 million.
  • Arcadia plans to scale three GoodWheat categories in 2024, with potential additions through acquisitions.
  • The company is working on closing transactions but has not provided a specific timeline.
  • Zola continues to face challenges but anticipates improvement and increased distribution with the introduction of new flavors in 2024.
  • Arcadia aims for double-digit growth in GoodWheat and Zola in 2024, focusing on expanding its existing accounts and attracting larger retailers.

Arcadia's growth in Q3 2023 was largely fueled by the success of GoodWheat pasta and Zola Coconut Water. The company also introduced GoodWheat into the breakfast category with pancake and waffle mixes and announced the launch of GoodWheat Mac & Cheese, which is expected to ship to over 350 stores by year-end.

The company is actively exploring strategic alternatives, including acquisitions, asset sales, mergers, and other transactions. The due diligence process with potential candidates has begun, but there is no set timetable for the conclusion of the strategic review.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Looking forward, Arcadia enters 2024 with plans to scale three GoodWheat categories and potentially add more through acquisitions. The company expects to capture more value in its supply chain and will provide updates in its next earnings call. For Zola, despite ongoing challenges, the company anticipates improvement and increased distribution with the introduction of new flavors in 2024.

Arcadia has streamlined its cost structure and is in a strong position for future growth, aiming for double-digit growth in GoodWheat and Zola in 2024. The company plans to nurture its current distribution footprint and expand its product lineup, focusing on existing accounts and becoming more attractive to larger retailers. Arcadia plans to have over 3,000 retail doors for its GoodWheat products by the end of 2023.

InvestingPro Insights

According to InvestingPro, Arcadia Biosciences (RKDA) holds more cash than debt on its balance sheet, which aligns with the reported $15.7 million in cash and short-term investments at the end of Q3. This financial stability may be crucial for the company's plans to explore strategic alternatives and expand its GoodWheat product line.

InvestingPro data also reveals that Arcadia's Price / Book ratio as of Q2 2023 was 0.2, suggesting that the company is trading at a low Price / Book multiple. This could be of interest to investors looking for potentially undervalued stocks.

However, it's important to note that Arcadia's stock has struggled recently, with a 1-year price total return of -75.15%. This aligns with InvestingPro's tip that the company's price has fallen significantly over the last year.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

InvestingPro offers a wealth of additional tips for RKDA, which could provide further insights into the company's financial health and future prospects.

Full transcript - RKDA Q3 2023:

Operator: Good afternoon and welcome to Arcadia Biosciences Third Quarter 2023 Financial Results and Business Highlights Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to T.J. Schaefer, Chief Financial Officer at Arcadia. Please go ahead.

T.J. Schaefer: Thank you, and good afternoon. Joining me on the call today is Stan Jacot, Arcadia’s President and Chief Executive Officer. This call is being webcast, and you can refer to the company’s press release at arcadiabio.com. Before we start, we would like to remind you that Arcadia Biosciences will be making forward-looking statements on this call based on current expectations and currently available information. However, since these statements are based on factors that involve risks and uncertainties, the company’s actual performance and results may differ materially from those described or implied today. You can review the company’s safe hard language in our most recently filed 10-Q. With that, I will now turn the call over to Stan.

Stan Jacot: Good afternoon, everyone. Thank you for joining us today for our 2023 third quarter conference call. I am pleased to report that Arcadia continues to make excellent progress in executing Project Greenfield, our 3-year strategic plan to unlock the company’s potential and provide a path to profitability. GoodWheat pasta and pancake mixes and Zola Coconut Water adds more than 1,000 stores of distribution in Q3 resulting in revenue growth from continued operations of 20% compared to last quarter. And we are operating with a leaner structure after the exit of our body care business as evidenced by our lowest total SG&A since 2019. I spoke last quarter about our plans to scale more quickly. And today, I want to provide an update on those key initiatives. First, GoodWheat Pasta is executing two programs that are expected to drive growth in Q4 and throughout 2024. The lower average price is now fully in market across more than 2,000 stores, and we expect this more competitive price point to result in higher turns and faster customer reorders. Q4 will also be the rollout of our new marketing messaging that GoodWheat is picky either approved with a clean plate guarantee, you will love it or your money back. We began this new messaging in October during National Pasta Month, resulting in over 14 million impressions and multiple social media influencer partnerships. The second key scaling initiative was the launch of GoodWheat into the breakfast category with new better-for-you Pancake & Waffle Mixes as well as Single-Serve Quikcakes. These new products are made with simple ingredients in Arcadia’s proprietary non-GMO wheat flour, which delivers the same case and texture of regular pancakes, but sneaks in more fiber and protein than traditional wheat flour. In product testing, consumers prefer the taste of GoodWheat Pancake mix 2:1 versus the leading better-for-you pancake mix. And I am pleased to report that retailers are recognizing this innovative proposition, and we will be shipping to over 750 stores by the end of the year. Not only will GoodWheat pasta and pancake mixes provide the foundation for growth in 2024, I have another GoodWheat initiative to announce today, the launch of GoodWheat Mac & Cheese. The Mac & Cheese category is over $1.1 billion in sales and has long been a household staple for families. Better-for-you brands make up nearly 20% of the category and are growing faster than traditional brands. Our GoodWheat Mac & Cheese packs in the most fiber of any brand in the category, 4x more than the leading brand. In fact, one serving a GoodWheat Mac & Cheese has the same fiber as two servings of oatmeal or 2.5 servings of broccoli. And just like our pasta and pancake mixes GoodWheat Mac & Cheese is higher in protein than leading brand with 12 grams of protein per serving. Our Mac & Cheese and Sneaky Delicious and picky-eater approved made with real cheese and no artificial flavors, dyes or preservatives. There are three varieties to choose from: Classic Cheddar, White Cheddar and Three Cheese. We start shipping into retailers this month and will be shipping to over 350 stores by the end of the year. And in February, we plan to have all 3 varieties available online at eatgoodwheat.com. For Zola Coconut Water, innovation has been our focus with the introduction of 2 new flavors, pineapple and lime to add to our original extra pulp and espresso flavors. Pineapple is the number one coconut water flavor and lime is the number one flavor in sparkling water. So we believe these new offerings will energize Zola sales. Both flavors are 100% natural, no sugar added and non-GMO. Launching in Q1 2024, these new flavors will be available in 16.9-ounce resealable containers. The last go initiative to discuss today is the strategic review announced on July 20, which stated that Arcadia would explore a range of strategic options, which could include an asset sale, acquisition, merger, sale or other strategic transactions. As we discussed in previous earnings calls, our strategic plan calls for an acquisition that would allow us to bring the GoodWheat value proposition to an existing business in our new wheat-based categories. We are beginning the due diligence process with potential candidates and are also evaluating asset sales and larger merger opportunities with our banking partner, and we’ll keep you updated as material events occur. However, we must point out that there can be no assurance that this exploration of strategic alternatives will result in the company entering or completing any transactions and no timetable has been set for the conclusion of the strategic review. With that, I’ll turn the call over to T.J. to discuss our Q3 financial results. T.J.?

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

T.J. Schaefer: Thank you, Stan, and good afternoon, everyone. Today, I will walk you through our third quarter financial highlights. In my prepared remarks, we’ll focus on our results from continuing operations, which excludes all body care related results for the period discussed. So let me spend just a few minutes providing some background as to why these brands are now being presented as discontinued operations. As you recall, we exited the Body Care co-packing business in the first half of 2022 and then made the decision to license the Savvy Naturals brand to Radian’s Beauty in July of 2022. At that time, we also ceased body care manufacturing activities and began using third-party manufacturers for ProVault and SoulSpring in an effort to simplify our business, focus our resources and increase our margins while freeing up cash. We considered GoodWheat, Zola and ProVault to be core brands that could offer attractive margins, provide differentiation and give us the ability to scale. However, the CBD category continued to face challenges that included one, a lack of distribution opportunities as the majority of U.S. retailers would not take CBD products, including online retailers, such as Amazon (NASDAQ:AMZN). Two, many retailers that did sell CBD put the product behind locked glass doors that had a negative impact on sales. Three, CBD products could not be marketed on large mainstream platforms such as Google (NASDAQ:GOOGL) Search, Facebook (NASDAQ:META) and Instagram, limiting our ability to advertise. And four, many retailers that once sold CBD made the decision to significantly reduce or completely step out of the category. As a result, we began to explore strategic alternatives for ProVault and SoulSpring at the beginning of 2023, but we’re unable to find a buyer. In June of 2023, we notified retailers that we would no longer be producing the product. And in September 2023, we stopped selling both brands. Given the strategic shift as well as the meaningful impact that all of these brands had on our prior year financial results, we made the decision to classify these businesses as discontinued operations in accordance with the guidance disclosures. Moving now to our results from continuing operations. Revenues of $1.6 million increased 2% year-over-year as higher sales of GoodWheat were largely offset by lost distribution at Zola that occurred at the end of 2022. On a sequential basis, revenues increased 20% in Q3 driven by increased GoodWheat distribution and higher sales of Zola. Gross margins in Q3 2023 were 31% compared to 28% in the prior year, which was in line with our expectations. On a year-to-date basis, our gross margins have increased nearly 1,500 basis points compared to the same period last year. Research and development expenses of $305,000 were $50,000 above prior year, but $86,000 below the prior quarter as a result of innovation work in Q2 2023 that resulted in the launch of Pancakes and Mac & Cheese. Selling, general and administrative expenses of $3.4 million were 18% below prior year and 4% below the prior quarter, primarily driven by lower headcount associated with the Body Care brands, as we discussed last quarter. And as Stan mentioned in his opening remarks, our SG&A expenses are now at the lowest level since 2019. We will continue to evaluate our expense profile in an effort to conserve cash. The reduction in expenses led to a 19% year-over-year improvement in our loss from continuing operations. We recorded $133,000 of interest income as well as a benefit of $608,000 from the change in the fair value of common stock warrant and option liabilities resulting in a net loss attributable to common stockholders of $2.5 million. Our cash and short-term investments at the end of Q3 2023 were $15.7 million a decline of $2.8 million compared to the previous quarter. We expect our use of cash to increase in the fourth quarter, driven by an estimated payment of $1 million related to the grow, out of approximately 6 million pounds of grain that will be used to produce Pasta and Mac & Cheese. Accounts receivable of $304,000 declined by $917,000 compared to the beginning of the year, driven by $1 million in milestone payments from Bioceres. As a reminder, we have now collected all milestone payments related to the Chinese approval of HB4 Soy. Total inventory of $4.3 million is approximately $1.2 million higher than the balance at the beginning of the year with approximately 80% of this inventory attributable to GoodWheat driven by production runs in May and September of 2023. We do not anticipate any production runs until Q2 of next year and plan to sell through our finished goods over the next six months. In conclusion, we are extremely pleased with the progress we have made so far. We have delivered positive gross profit from continuing operations for seven consecutive quarters, have reduced our SG&A expenses to the lowest level in 4 years, lowered our cash burn to less than $3 million in the latest quarter. And we now enter 2024 and with the opportunity to scale three GoodWheat categories and the potential to add additional categories through acquisition. With that, I will now turn the call back over to the operator for questions.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Operator: [Operator Instructions] Our first question comes from the line of Dipesh Patel from H.C. Wainwright & Co. Your line is now open.

Dipesh Patel: Hi. Thanks T.J. This is Dipesh, standing in for Ram Selvaraju. Is there anything else that you can highlight as you look at strategic alternatives, maybe including timelines? And then also what progress has been made in capturing additional economics in the value chain for GoodWheat? So, some comments around that would be helpful. Thank you.

Stan Jacot: Yes. Thank you, Dipesh and thanks for calling in today. So, for your first question, we don’t have a timeline that we are ready to give in terms of closing any transactions, but there are several, that are in our pipeline and we are continuing to work diligently to do the right steps. In terms of capturing value through the rest of our supply chain, we do have several agreements that are in front of some of our partners. And we do expect more news on that front in our next earnings call.

Dipesh Patel: Great. It’s very helpful. Thanks again for the update today.

Operator: Thank you. [Operator Instructions] Our next question comes from the line of Ben Klieve from Lake Street Capital Markets. Your line is now open.

Ben Klieve: Thanks for taking my questions and congratulations guys. Nice little quarter here from top to bottom, it seems. Have a handful of questions for you. First of all, on Zola, it sounds like some of the momentum that you saw in Zola in the second quarter really continued into the third quarter. Excluding the impact of new – the new flavors that are coming online, can you comment on Zola’s contributions to the top line and retail distribution today versus the Thai watermark a few quarters ago before some of the challenges emerged?

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Stan Jacot: Yes, sure and thanks for calling in today, Ben. For Zola, yes, the challenges that we had last quarter or in Q4 of 2022, they are still continuing. And so we are going to expect to lap those by Q4 of 2023. We have seen incremental distribution, and we have seen velocities also start to improve. But we do expect the innovation to be a catalyst for more distribution in 2024.

Ben Klieve: Okay. Perfect. Thank you. The – I am curious, with GoodWheat retail placements now 15-months-old, maybe a little more, I am wondering if you can talk about kind of the lessons that you took from the initial placements a year ago and how you are driving growth now from new retail stores in maybe a more accelerated manner now. I mean what challenges did you guys run into a year ago that you are not running into today? Any insights there would be helpful.

Stan Jacot: Yes. So, if we go back 15 months, it was GoodWheat Pasta that we had launched, and we were successful in gaining distribution in a number of different accounts, different size accounts, different regions of the country. We have had lots of great learning as we had spoken on earlier conference calls about on price points and where we need to be in comparison to other better-for-you brands. We have also been learning about shelf placement, number of SKUs on shelf, the promoted pricing programs. So, all of those factors are going into ways that we can optimize our current distribution footprint. So, I think that’s really the focus for the pasta category is making sure that we are nurturing those accounts and those SKUs that we have distribution. And in some accounts, there is opportunities to expand our lineup to include more of the pasta SKUs. So, I think that’s really what our key learnings for pasta. And we are also applying those learnings as we have launched the pancake category and now more recently, the Mac & Cheese category.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Ben Klieve: Okay. Great. T.J., a clarifying question, on your prepared remarks, did I hear you call out costs in the third quarter associated with Mac & Cheese and Pancakes, I believe, or am I making that up?

T.J. Schaefer: Yes. No. So, I called out R&D expenses that they were higher in Q2 related to preparing for the launches of Pancakes and Mac & Cheese.

Ben Klieve: Okay. So, R&D costs in Q2 were directionally higher for – given both of those products, okay. I thought I missed an explicit number, okay. And then last question for me. I mean the – it looks like a lot of momentum is really built through 2023 so far. I mean as you look into 2024, can you guys give any kind of high-level expectations regarding overall retail doors that you hope to be at ending ‘24, any kind of high-level metrics that you can really provide to help us get a sense of kind of the scale you are looking at 12 months from now?

Stan Jacot: Yes, sure. I think when we add up the three categories for GoodWheat, we will be over 3,000 doors ending 2023. And in 2024, our plan is really to nurture those 3,000 doors. There may be additional accounts that come online in the first half of the year. But really, we want to make sure that we are growing where we are and that we become almost indispensably attractive to the larger retailers in the larger – in the accounts that we are today. So, we are still planning on double-digit growth for GoodWheat next year and then I would say the same for Zola.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Ben Klieve: Got it. Okay. Very good. Plenty more to talk about. That’s a good place to leave it. Thanks for taking my questions and congratulations again on a really nice quarter here.

Stan Jacot: Thank you.

Operator: I am showing no further questions at this time. I would now like to turn it back to Stan Jacot for closing remarks.

Stan Jacot: In summary, as we enter 2024, Arcadia is in the best position in its history. Our proprietary wheat technology has been commercialized in three categories with the potential to add more categories through acquisition. We have exited the low opportunity and high resource body care business and are revitalizing the Zola Coconut Water brand with innovation rolling out early next year. This has resulted in stronger top line growth and higher gross margins. And finally, we have right-sized the organization and streamlined our cost structure in order to extend our runway to execute our plan. We look forward to updating you in the future. Thanks again for joining us and have a great rest of your day.

Operator: Thank you for your participation in today’s conference. This does conclude the program. You may now disconnect.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.